M. Marije Vis

Showing 1-11 of 11 articles

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial

Kerkmeijer L, Tijssen RY, Hofma S, van der Schaaf R, Arkenbout K, Kraak R, Weevers A, Piek J, de Winter R, Tijssen J, Henriques J, Wykrzykowska J, Ijsselmuiden A, Kauer F, Beijk M, Vis M, Koch K

September 20, 2019 | 10.4244/EIJ-D-19-00325

Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial

Barbanti M, van Mourik M, Spence M, Iacovelli F, Martinelli G, Muir D, Saia F, Bortone A, Densem C, van der Kley F, Bramlage P, Vis M, Tamburino C

June 20, 2019 | 10.4244/EIJ-D-18-01197

Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI

Tijssen RY, Kraak R, Hofma S, van der Schaaf R, Arkenbout E, Weevers A, Elias J, van Dongen I, Koch K, Baan Jr J, Vis M, de Winter R, Piek J, Tijssen J, Henriques J, Wykrzykowska J

July 20, 2018 | 10.4244/EIJ-D-18-00335

Coronary interventions

Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria

Kraak R, Grundeken M.J, Hassell M, Elias J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Thijssen J, de Winter R, Wykrzykowska J

August 5, 2016 | 10.4244/EIJV12I5A95

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry

Kraak R, Hassell M, Grundeken M.J, Koch K, Henriques J, Piek J, Baan Jr J, Vis M, Arkenbout E, Thijssen J, de Winter R, Wykrzykowska J

February 20, 2015 | 10.4244/EIJY14M08_08

Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus

Hoebers L, Claessen B, Woudstra P, De Vries J, Wykrzykowska J, Vis M, Baan Jr J, Koch K, Thijssen J, de Winter R, Piek J, Henriques J

May 20, 2014 | 10.4244/EIJV10I1A15

Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies

Grundeken M.J, Asgedom S, Damman P, Lesiak M, Norell M, Garcia E, Bethencourt A, Woudstra P, Koch K, Vis M, Henriques J, Onuma Y, Foley DP, Bartorelli A, Stella P, Thijssen J, de Winter R, Wykrzykowska J

June 28, 2013 | 10.4244/EIJV9I2A34

Acute haemodynamic effects of accelerated idioventricular rhythm in primary percutaneous coronary intervention

Delewi R, Remmelink M, Meuwissen M, van Royen N, Vis M, Koch K, Henriques J, de Winter R, Thijssen J, Baan Jr J, Piek J

August 30, 2011 | 10.4244/EIJV7I4A76

Long-term safety and sustained left ventricular recovery: long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction

Engstrom A, Sjauw K, Baan Jr J, Remmelink M, Claessen B, Kikkert W, Hoebers L, Vis M, Koch K, Meuwissen M, Thijssen J, de Winter R, Piek J, Henriques J

February 21, 2011

The effect of repeated ischaemic periods on left ventricular dynamics during percutaneous coronary intervention

Remmelink M, de Winter R, Henriques J, Koch K, van der Schaaf R, Vis M, Thijssen J, Piek J, Baan Jr J

November 15, 2010

The influence of gender on short- and long-term outcome after primary PCI and delivered medical care for ST-segment elevation myocardial infarction

Sjauw K, Stegenga N, Engstrom A, van der Schaaf R, Vis M, Macleod A, Baan Jr J, Koch K, de Winter R, Thijssen J, Piek J, Henriques J

February 25, 2010

1

Latest news

"Shocktopics” with intravascular lithotripsy, bioprosthetic valve fracture, myocardial fibrosis in TAVI...

Reimaged models and angiograms showing CO March 17, 2020

New ahead of print: Infolding of self expanding valve during transcatheter aortic valve implantation

Nandhakumar Vasu et al

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Christian Spaulding

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Defining procedural MI - does it matter (spoiler alert - it does!)

This week’s JAA’s: QFR in severe AS & Infection control for TAVI

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke